LONG-TERM COST-UTILITY ANALYSIS OF TREATMENT STRATEGIES IN PATIENTS WITH RECENT-ONSET RHEUMATOID ARTHRITIS-5 YEAR FOLLOW-UP DATA FROM THE BEST STUDY